Daniel S. Everdeen
Pfizer (United States)(US)University of California, Berkeley(US)
Publications by Year
Research Areas
Immune Response and Inflammation, NF-κB Signaling Pathways, Phytochemicals and Antioxidant Activities, Antifungal resistance and susceptibility, Enzyme Catalysis and Immobilization
Most-Cited Works
- → CD40−Tumor Necrosis Factor Receptor-Associated Factor (TRAF) Interactions: Regulation of CD40 Signaling through Multiple TRAF Binding Sites and TRAF Hetero-Oligomerization(1998)246 cited
- → Structure-guided inhibitor design for human FAAH by interspecies active site conversion(2008)151 cited
- → High-Affinity Interactions of Tumor Necrosis Factor Receptor-Associated Factors (TRAFs) and CD40 Require TRAF Trimerization and CD40 Multimerization(1999)148 cited
- → Enzymic Cross-Linkage of Monomeric Extensin Precursors in Vitro(1988)95 cited
- → Recombinant human CNTF receptor .alpha.: production, binding stoichiometry, and characterization of its activity as a diffusible factor(1994)30 cited
- → Deletion of Individual mRNA Capping Genes Is Unexpectedly Not Lethal to Candida albicans and Results in Modified mRNA Cap Structures(2002)14 cited
- → Crystal Structure of fatty acid amide hydrolase conjugated with the drug-like inhibitor PF-750(2008)